Literature DB >> 4583348

A modified agarose method for detection of migration inhibitory factor and delineation of its antigen dependency.

R H Weisbart, J E Cunningham, R Bluestone, L S Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4583348     DOI： 10.1159/000231104

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN： 0020-5915


× No keyword cloud information.
  7 in total

1.  Lymphocyte response to IgG in patients with ankylosing spondylitis and their families.

Authors:  R H Weisbart; R I Morris; P I Terasaki; R Bluestone; L S Goldberg
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Cell mediated immunity to recall antigens in vivo and in vitro.

Authors:  A M Hassett; R J Woods; I J Temperley; G M Mullins
Journal:  Ir J Med Sci       Date:  1977-06       Impact factor: 1.568

3.  Migration enhancement factor: a new lymphokine.

Authors:  R H Weisbart; R Bluestone; L S Goldberg; C M Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

4.  Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.

Authors:  A J Górski; B Dupont; J A Hansen; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Human polymorphonuclear leucocyte migration inhibitory factor. Evidence for antigen dependency.

Authors:  R H Weisbart; J Isaacson; R Bluestone; L S Goldberg
Journal:  Immunology       Date:  1975-08       Impact factor: 7.397

6.  Alterations in mouse macrophage migration: a function of assay systems, lymphocyte activation product preparation, and fractionation.

Authors:  P L Sandok; R D Hinsdill; R M Albrecht
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

Review 7.  Prostate cancer.

Authors:  Richard J Rebello; Christoph Oing; Karen E Knudsen; Stacy Loeb; David C Johnson; Robert E Reiter; Silke Gillessen; Theodorus Van der Kwast; Robert G Bristow
Journal:  Nat Rev Dis Primers       Date:  2021-02-04       Impact factor: 52.329
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.